Eli Lilly (NYSE:LLY) has entered into a licensing agreement with Mediar Therapeutics to advance Mediar's drug MTX-463 into ...
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 494.50% and ...
Juan M. Morales Juan M. Morales, a devoted husband, father, grandfather, and friend, peacefully passed away at home on Dec. 31, 2024, at the age of 87, ...
Eli Lilly in talks to acquire cancer biotech Scorpion Therapeutics for $2.5 billion, with potential milestone payments.
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
Not only was the role transformative for the singer and actress, but on set of Wicked, she met her boyfriend, Ethan Slater, ...
FDA's Center for Drug Evaluation and Research director, Patrizia Cavazzoni, MD, to step down in mid-January. Other top leaders also leaving FDA.
Lawsuit by New Orleans truck attack victims says city, contractors failed to implement safety system
The contractors and the city failed to implement an effective system for deterring such a threat, the suit said.
The 2025 roster of 18 gymnasts features 12 returners and six true freshmen (Love Birt, Brooke Dennis, Ryan Fuller, Kylee ...
Venture capital firm Andreessen Horowitz said on Friday it was working with Eli Lilly to launch a $500 million venture fund that will be fully funded by the U.S. drugmaker.
Victims of the Bourbon Street incident sue New Orleans for lack of safety barriers, seeking compensation for the tragedy ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback